Literature DB >> 33498689

Tear-Derived Exosome Proteins Are Increased in Patients with Thyroid Eye Disease.

Jeong-Sun Han1, Sung Eun Kim2, Jun-Qing Jin1, Na Ri Park2, Ji-Young Lee3, Hong Lim Kim4, Seong-Beom Lee3, Suk-Woo Yang2, Dong-Jun Lim1.   

Abstract

Exosomes contain proteins, lipids, RNA, and DNA that mediate intercellular signaling. Exosomes can contribute to the pathological processes of various diseases, although their roles in ocular diseases are unclear. We aimed to isolate exosomes from tear fluids (TF) of patients with Thyroid eye disease (TED) and analyze the exosomal proteins. TFs were collected from eight patients with TED and eight control subjects. The number of TF exosomes were measured using nanoparticle-tracking analysis. The expression of specific proteins in the purified exosome pellets were analyzed using a Proteome Profiler Array Kit. Cultured normal orbital fibroblasts were incubated with TF exosomes from patients with TED and control subjects, and changes in inflammatory cytokine levels were compared. TF exosomes from TED patients showed more exosomes than the control subjects. The expression levels of exosomal proteins vitamin D-binding (VDB) protein, C-reactive protein (CRP), chitinase 3-like 1 (CHI3L1), matrix metalloproteinase-9 (MMP-9), and vascular adhesion molecule-1 (VCAM-1) were significantly increased in patients with TED, compared to those of controls. Orbital fibroblasts exposed to TF exosomes from patients with TED showed significantly higher levels of interleukin (IL)-6, IL-8, and monocyte chemoattractant protein-1 (MCP-1) production than those treated with control TF exosomes. Specific proteins showed higher expression in exosomes from TED patients, implying that they may play keys roles in TED pathogenesis.

Entities:  

Keywords:  Graves’ ophthalmopathy; eear fluids; ehyroid-associated ophthalmopathy; exosomes; extracellular vesicle; eytokines

Year:  2021        PMID: 33498689      PMCID: PMC7866068          DOI: 10.3390/ijms22031115

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  51 in total

Review 1.  The ocular surface in thyroid diseases.

Authors:  Piera Versura; Emilio C Campos
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-10

2.  ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model.

Authors:  Chi-Ling Chiang; Swagata Goswami; Frank W Frissora; Zhiliang Xie; Pearlly S Yan; Ralf Bundschuh; Logan A Walker; Xiaomeng Huang; Rajeswaran Mani; Xiaokui M Mo; Sivasubramanian Baskar; Christoph Rader; Mitch A Phelps; Guido Marcucci; John C Byrd; L James Lee; Natarajan Muthusamy
Journal:  Blood       Date:  2019-05-31       Impact factor: 22.113

3.  Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease.

Authors:  Shanli Tsui; Roshini Fernando; Beiling Chen; Terry J Smith
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

Review 4.  Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.

Authors:  D H Jacobson; C A Gorman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

Review 5.  Chitinase 3 Like-1: An Emerging Molecule Involved in Diabetes and Diabetic Complications.

Authors:  Michelino Di Rosa; Lucia Malaguarnera
Journal:  Pathobiology       Date:  2016-05-18       Impact factor: 4.342

6.  Interleukin-7 expression in tears and orbital tissues of patients with Graves' ophthalmopathy.

Authors:  KeBo Cai; RuiLi Wei
Journal:  Endocrine       Date:  2012-11-28       Impact factor: 3.633

7.  Tear Proteins Calcium binding protein A4 (S100A4) and Prolactin Induced Protein (PIP) are Potential Biomarkers for Thyroid Eye Disease.

Authors:  Chiaw-Ling Chng; Lay Leng Seah; Morgan Yang; Sunny Yu Shen; Siew Kwan Koh; Yan Gao; Lu Deng; Louis Tong; Roger Wilmer Beuerman; Lei Zhou
Journal:  Sci Rep       Date:  2018-11-16       Impact factor: 4.379

8.  Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.

Authors:  Lara A Aqrawi; Hilde Kanli Galtung; Eduarda M Guerreiro; Reidun Øvstebø; Bernd Thiede; Tor Paaske Utheim; Xiangjun Chen; Øygunn Aass Utheim; Øyvind Palm; Kathrine Skarstein; Janicke Liaaen Jensen
Journal:  Arthritis Res Ther       Date:  2019-07-31       Impact factor: 5.156

9.  Aqueous two-phase system to isolate extracellular vesicles from urine for prostate cancer diagnosis.

Authors:  Hyunwoo Shin; Yong Hyun Park; Yong-Goo Kim; Ji Youl Lee; Jaesung Park
Journal:  PLoS One       Date:  2018-03-27       Impact factor: 3.240

Review 10.  Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review.

Authors:  Nickisa M Hodgson; Fatemeh Rajaii
Journal:  Ophthalmol Ther       Date:  2019-12-10
View more
  4 in total

1.  Biofluids manipulation methods for liquid biopsy in minimally-invasive assays.

Authors:  Valeria Garzarelli; Francesco Ferrara; Elisabetta Primiceri; Maria Serena Chiriacò
Journal:  MethodsX       Date:  2022-06-17

Review 2.  The Roles of Exosomes in Immunoregulation and Autoimmune Thyroid Diseases.

Authors:  Junli Zou; Huiyong Peng; Yingzhao Liu
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

Review 3.  Research progress on the pathogenesis of Graves' ophthalmopathy: Based on immunity, noncoding RNA and exosomes.

Authors:  Jingyi Zheng; Honghong Duan; Sufang You; Bo Liang; Yuping Chen; Huibin Huang
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

4.  Current insights of applying MRI in Graves' ophthalmopathy.

Authors:  Cheng Song; Yaosheng Luo; Genfeng Yu; Haixiong Chen; Jie Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.